Abstract：
BACKGROUND:Estrogen receptor positive breast cancers have high recurrence rates despite tamoxifen therapy. Breast cancer stem/progenitor cells (BCSCs) initiate tumors, but expression of estrogen (ER) or progesterone receptors (PR) and response to tamoxifen is unknown. Interleukin-6 (IL-6) and interleukin-8 (IL-8) may influence tumor response to therapy but expression in BCSCs is also unknown. METHODS:BCSCs were isolated from breast cancer and benign surgical specimens based on CD49f/CD24 markers. CD44 was measured. Gene and protein expression of ER alpha, ER beta, PR, IL-6 and IL-8 were measured by proximity ligation assay and qRT-PCR. RESULTS:Gene expression was highly variable between patients. On average, BCSCs expressed 10-106 fold less ERα mRNA and 10-103 fold more ERβ than tumors or benign stem/progenitor cells (SC). BCSC lin-CD49f-CD24-cells were the exception and expressed higher ERα mRNA. PR mRNA in BCSCs averaged 10-104 fold less than in tumors or benign tissue, but was similar to benign SCs. ERα and PR protein detection in BCSCs was lower than ER positive and similar to ER negative tumors. IL-8 mRNA was 10-104 higher than tumor and 102 fold higher than benign tissue. IL-6 mRNA levels were equivalent to benign and only higher than tumor in lin-CD49f-CD24-cells. IL-6 and IL-8 proteins showed overlapping levels of expressions among various tissues and cell populations. CONCLUSIONS:BCSCs and SCs demonstrate patient-specific variability of gene/protein expression. BCSC gene/protein expression may vary from that of other tumor cells, suggesting a mechanism by which hormone refractory disease may occur.
journal_name
BMC Cancerjournal_title
BMC cancerauthors
Schillace RV,Skinner AM,Pommier RF,O'Neill S,Muller PJ,Naik AM,Hansen JE,Pommier SJdoi
10.1186/1471-2407-14-733subject
Has Abstractpub_date
2014-09-30 00:00:00pages
733issn
1471-2407pii
1471-2407-14-733journal_volume
14pub_type
杂志文章相关文献
BMC CANCER文献大全abstract：BACKGROUND:Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death in the world. N6-methyladenosine (m6A) RNA methylation is dynamically regulated by m6A RNA methylation modulators ("writer," "eraser," and "reader" proteins), which are associated with cancer occurrence and development. Th...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-6638-5
更新日期：2020-02-28 00:00:00
abstract：BACKGROUND:Aberrant methylation is a frequent event in oral cancer. METHODS:In order to better characterize these alterations, a search for genes downregulated by aberrant methylation in oral squamous cell carcinoma (OSCC) was conducted through the mining of ORESTES dataset. Findings were further validated in OSCC cel...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-4077-3
更新日期：2018-02-17 00:00:00
abstract：BACKGROUND:Cytochrome P450 1B1 (CYP1B1) has been shown to be up-regulated in many types of cancer including renal cell carcinoma (RCC). Several reports have shown that CYP1B1 can influence the regulation of tumor development; however, its role in RCC has not been well investigated. The aim of the present study was to d...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1951-0
更新日期：2015-12-01 00:00:00
abstract：BACKGROUND:Recent studies have extensively investigated the role of miRNAs in colorectal cancer (CRC), and several associations have been reported. In addition, single nucleotide polymorphisms (SNPs) in promoter regions of miRNAs have been shown to affect miRNA expression. Therefore, we aimed to analyze the effect of m...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5641-1
更新日期：2019-05-22 00:00:00
abstract：BACKGROUND:Pancreatic adenocarcinoma is one of the most dreaded cancers with very low survival rate and poor prognosis to the existing frontline chemotherapeutic drugs. Gene therapy in combination with a cytotoxic agent could be a promising approach to circumvent the limitations of previously attempted therapeutic inte...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-75
更新日期：2014-02-08 00:00:00
abstract：BACKGROUND:Toll-like receptor 3 (TLR3) is a critical component of the innate immune response to dsRNA viruses, which was considered to be mainly expressed in immune cells and some endothelial cells. In this study, we investigated the expression and proapoptotic activity of TLR3 in human and murine tumor cell lines. ME...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-8-12
更新日期：2008-01-17 00:00:00
abstract：BACKGROUND:Myeloid-derived suppressor cells (MDSCs) is a heterogeneous population of immature myeloid cells, inhibiting both the innate and adaptive immunity. Recent studies validated that MDSCs caused immune suppression and promoted cancer progression through various mechanisms. However, the prognostic value of MDSCs ...
journal_title：BMC cancer
pub_type： 杂志文章,meta分析
doi：10.1186/s12885-018-5086-y
更新日期：2018-12-05 00:00:00
abstract：BACKGROUND:Previous studies have suggested that metformin may be useful for preventing and treating endometrial cancer (EC), while the results have been inconsistent. This systematic review and meta-analysis aimed to investigate the association between metformin use and risk and prognosis of patients with EC. METHODS:...
journal_title：BMC cancer
pub_type： 杂志文章,meta分析,评审
doi：10.1186/s12885-018-4334-5
更新日期：2018-04-18 00:00:00
abstract：BACKGROUND:Glioblastomas (GBMs) are highly malignant brain tumours with a poor prognosis, and current cytotoxic regimens provide only a limited survival benefit. The PI3K/Akt/mTOR pathway has been an attractive target for therapy due to its high activation in GBMs as well as other cancers. The dual pan-PI3K/mTOR kinase...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2712-4
更新日期：2016-08-19 00:00:00
abstract：BACKGROUND:The epithelial cell adhesion molecule (EpCAM) has been shown to be overexpressed in breast cancer and stem cells and has emerged as an attractive target for immunotherapy of breast cancer patients. This study analyzes the effects of EpCAM on breast cancer cell lines with epithelial or mesenchymal phenotype. ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-501
更新日期：2012-10-30 00:00:00
abstract：BACKGROUND:Accurate assessment of HER-2/neu status is crucial for proper prognostic information and to offer direct appropriate treatment for breast cancer patients. Next to immunohistochemistry (IHC) to evaluate HER2 protein overexpression, a second line gene amplification test is generally deemed necessary for cases ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-4
更新日期：2009-01-05 00:00:00
abstract：BACKGROUND:Weekly docetaxel has occasionally been used in the neoadjuvant to downstage breast cancer to reduce toxicity and possibly enhance quality of life. However, no studies have compared the standard three weekly regimen to the weekly regimen in terms of quality of life. The primary aim of our study was to compare...
journal_title：BMC cancer
pub_type： 临床试验,杂志文章,随机对照试验
doi：10.1186/1471-2407-11-179
更新日期：2011-05-18 00:00:00
abstract：BACKGROUND:Comorbidity has a well documented detrimental effect on cancer survival. However it is difficult to disentangle the direct effects of comorbidity on survival from indirect effects via the influence of comorbidity on treatment choice. This study aimed to assess the impact of comorbidity on colon cancer patien...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-116
更新日期：2009-04-20 00:00:00
abstract：BACKGROUND:Little is known about colorectal adenoma patients' ability to adhere to behavioural interventions promoting a change in diet and physical activity. This review aimed to examine health behaviour intervention programmes promoting change in diet and/or physical activity in adenoma patients and characterise inte...
journal_title：BMC cancer
pub_type： 杂志文章,meta分析,评审
doi：10.1186/s12885-015-1502-8
更新日期：2015-07-07 00:00:00
abstract：BACKGROUND:This study aimed to explore the heterogeneity of circRNA expression pattern via microarray, and further evaluate the potential of 10 specific circRNAs as diagnostic and prognostic biomarkers in multiple myeloma (MM). METHODS:In exploration stage (stage I), circRNA expression profiles were detected by the mi...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-6515-2
更新日期：2020-01-16 00:00:00
abstract：BACKGROUND:Muscle invasive bladder cancer (MIBC) is often lethal and non-MIBC (NMIBC) can recur and progress, yet prognostic markers are currently inadequate. SAM68, a member of RNA-binding proteins, has been reported to contribute to progression of other cancers. The aim of this study is to investigate the potential u...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1367-x
更新日期：2015-05-06 00:00:00
abstract：BACKGROUND:Triple-negative (TN) breast cancer, which is defined as being negative for the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER-2), represents a subset of breast cancer with different biologic behaviour. We investigated the clinicopathologic charac...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-8-307
更新日期：2008-10-23 00:00:00
abstract：BACKGROUND:Reports on childhood cancer survivors estimated cumulative probability of developing secondary neoplasms vary from 3.3% to 25% at 25 years from diagnosis, and the risk of developing another cancer to several times greater than in the general population. METHODS:In our retrospective study, we have used the c...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-7-27
更新日期：2007-02-02 00:00:00
abstract：BACKGROUND:A major impediment in the treatment of ovarian cancer is the relapse of chemotherapy-resistant tumors, which occurs in approximately 25% of patients. A better understanding of the biological mechanisms underlying chemotherapy resistance will improve treatment efficacy through genetic testing and novel therap...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-020-06922-1
更新日期：2020-05-13 00:00:00
abstract：BACKGROUND:A universal hallmark of cancer cells is the change in their glycosylation phenotype. One of the most frequent alterations in the normal glycosylation pattern observed during carcinogenesis is the enhancement of α(1,6)linked fucose residues of glycoproteins, due to the up-regulation of the α(1,6)fucosyltransf...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-11-508
更新日期：2011-12-07 00:00:00
abstract：BACKGROUND:The differentiation of pancreatic ductal adenocarcinoma (PDAC) could be associated with prognosis and may influence the choices of clinical management. No applicable methods could reliably predict the tumor differentiation preoperatively. Thus, the aim of this study was to compare the metabonomic profiling o...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3703-9
更新日期：2017-11-02 00:00:00
abstract：BACKGROUND:Increased level of serum S100B can serve as a marker of metastatic spread in patients with cutaneous melanoma (CM). In patients with elevated S100 B and/or clinical signs of disease progression PET-CT scan is a valuable tool for discovering metastases and planning treatment.The aims of this study were to det...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-11-328
更新日期：2011-08-02 00:00:00
abstract：BACKGROUND:Amplification of the 8p11-12 region has been found in approximately 15% of human breast cancer and is associated with poor prognosis. Previous genomic analysis has led us to identify the endoplasmic reticulum (ER) lipid raft-associated 2 (ERLIN2) gene as one of the candidate oncogenes within the 8p11-12 ampl...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-225
更新日期：2012-06-08 00:00:00
abstract：BACKGROUND:Breast cancer in women is increasingly frequent, and care is complex, onerous and expensive, all of which lend urgency to improvements in care. Quality measurement is essential to monitor effectiveness and to guide improvements in healthcare. METHODS:Ten databases, including Medline, were searched electroni...
journal_title：BMC cancer
pub_type： 杂志文章,评审
doi：10.1186/1471-2407-6-291
更新日期：2006-12-18 00:00:00
abstract：BACKGROUND:Castleman's disease is a rare form of localized lymph node hyperplasia of uncertain etiology. Although the mediastinum is the most common site of involvement, rare cases occurring in lymph node bearing tissue of other localization have been reported, including only a few intramuscular cases. Unicentric and m...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-11-352
更新日期：2011-08-12 00:00:00
abstract：BACKGROUND:Thyroid transcription factor (TTF)-1 expression is a diagnostic marker and a good prognostic indicator for lung adenocarcinoma. However, its good prognostic ability might be due to epidermal growth factor receptor (EGFR)-sensitizing mutations as shown by the positive correlation between TTF-1 expression and ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5792-0
更新日期：2019-06-13 00:00:00
abstract：BACKGROUND:The human leucine-rich, repeat-containing G protein-coupled receptor 5 (LGR5) is a stem cell marker in numerous adult tissues and is overexpressed in a large number of human carcinoma including colon cancer, breast cancer and oral squamous cell carcinomas (OSCC). The role of the full length transcript (LGR5F...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5327-8
更新日期：2019-02-15 00:00:00
abstract：BACKGROUND:Estrogen (17β-estradiol) promotes the survival and proliferation of breast cancer cells and its receptors represent important therapeutic targets. The cellular actions of estrogen are mediated by the nuclear estrogen receptors ERα and ERβ as well as the 7-transmembrane spanning G protein-coupled estrogen rec...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-015-1699-6
更新日期：2015-10-15 00:00:00
abstract：BACKGROUND:Papillary carcinomas that measure 1.0cm or less are diagnosed as papillary thyroid microcarcinomas (PTMs). The clinical significance and recommendations for management of these PTMs is still evolving. The objective of the study was to compare the characteristics of small (<5mm) to large (≥ 5mm) papillary thy...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3120-0
更新日期：2017-02-16 00:00:00
abstract：BACKGROUND:Cell migration and invasion are essential processes for metastatic dissemination of cancer cells. Significant progress has been made in developing new therapies against oncogenic signaling to eliminate cancer cells and shrink tumors. However, inherent heterogeneity and treatment-induced adaptation to drugs c...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6479-2
更新日期：2020-01-02 00:00:00
